Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
Allergy Asthma Immunol Res. 2011 Apr;3(2):128-31. doi: 10.4168/aair.2011.3.2.128. Epub 2010 Sep 6.
H(2)-receptor antagonists, such as cimetidine, ranitidine and famotidine, are some of the most commonly prescribed medications for gastric acid-related disorders. These compounds are generally well-tolerated and anaphylactic reactions to them are rare. Here, we report two cases of H(2)-receptor antagonist-induced anaphylactic reactions: the first presented with sudden dyspnea, sneezing, urticaria, and swelling of the eyelids after ranitidine intake. The second presented with sudden severe urticaria, facial swelling, chest discomfort, dizziness, and hypotension. Possible cross-reactivity with other H(2)-receptor antagonists was assessed by oral challenge and skin tests. To date, only a few reports addressing cross-reactivity among H(2)-receptor antagonists have been published. We review the literature and summarize the data available on drug cross-reactivity in H(2)-receptor antagonist hypersensitivity.
H2-受体拮抗剂,如西咪替丁、雷尼替丁和法莫替丁,是治疗胃酸相关疾病最常用的药物之一。这些化合物通常耐受性良好,过敏反应很少见。在这里,我们报告了两例 H2-受体拮抗剂引起的过敏反应病例:第一例在服用雷尼替丁后突然出现呼吸困难、打喷嚏、荨麻疹和眼睑肿胀。第二例突然出现严重荨麻疹、面部肿胀、胸部不适、头晕和低血压。通过口服挑战和皮肤试验评估与其他 H2-受体拮抗剂的可能交叉反应性。迄今为止,只有少数几篇关于 H2-受体拮抗剂之间交叉反应性的报道。我们回顾了文献,并总结了 H2-受体拮抗剂过敏中药物交叉反应性的现有数据。